PEGylated antibodies and antibody fragments for improved therapy: a review
Top Cited Papers
- 18 April 2002
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 54 (4), 531-545
- https://doi.org/10.1016/s0169-409x(02)00026-1
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Pharmacokinetics of Monoclonal AntibodiesClinical Immunotherapeutics, 1996
- PEG Thiazolidine-2-thione, a Novel Reagent for Facile Protein Modification: Conjugation of Bovine HemoglobinBioconjugate Chemistry, 1996
- Preparation and Characterization of Poly(ethylene glycol) Vinyl SulfoneBioconjugate Chemistry, 1996
- Functionalized Poly(ethylene glycols) for Preparation of Biologically Relevant ConjugatesBioconjugate Chemistry, 1995
- Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibodyMolecular Immunology, 1993
- Comparative Pharmacokinetic Properties of Murine Monoclonal Antibody A7 Modified with Neocarzinostatin, Dextran and Polyethylene GlycolJapanese Journal of Cancer Research, 1991
- Polyethylene glycol modification of the monoclonal antibody A7 enhances its tumor localizationBiochemical and Biophysical Research Communications, 1990
- The binding site for C1q on IgGNature, 1988
- Localization of the binding site for the human high-affinity Fc receptor on IgGNature, 1988
- Physicochemical and biological properties of poly(ethylene glycol)-coupled immunoglobuling GBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1984